Fisetin: a flavonol from strawberries, apples and onions

Fisetin is a naturally occurring flavonoid found in a range of fruits and vegetables, in particular in strawberries, apples and onions. It belongs to the flavonol subgroup of the polyphenols and has attracted increasing attention in scientific research in recent years. Fisetin is characterised by its antioxidant activity in laboratory assays, by its effects on inflammatory signalling in cells and by its activity against senescent cells in animal models. These properties make it a candidate molecule for research on ageing and age-related conditions.

Mechanisms examined in the laboratory

Antioxidant properties. In chemical assays, fisetin acts as an antioxidant that neutralises free radicals. Free radicals are unstable molecules that can cause cell damage and are discussed in connection with various chronic conditions and with the ageing process. In cell culture, fisetin was associated with lower markers of oxidative stress. Whether this activity is relevant in the human body, where flavonols are rapidly metabolised, is an open question.

Inflammatory signalling. A further area of fisetin research concerns inflammation. Chronic inflammation is regarded in the scientific literature as a major factor in many age-related conditions, including heart disease, diabetes and neurodegenerative conditions. In cell and animal models, fisetin modulated several signalling pathways involved in the inflammatory response and lowered the production of pro-inflammatory cytokines.

Senolytic properties. In 2018, a screening study in mice and in human tissue samples identified fisetin as a senolytic, that is a compound that selectively removes senescent cells. Senescent cells are aged cells that have stopped dividing and release inflammation-promoting substances. These so-called zombie cells are discussed as a contributor to tissue ageing and to various age-related conditions. In the mouse study, intermittent fisetin administration reduced the number of senescent cells in tissues and extended the lifespan of old mice. Clinical trials in humans are ongoing; their results are not yet available.

Research areas

Cognitive function. Studies in animal models have examined fisetin in relation to cognitive function. In a mouse model of Alzheimer disease, fisetin administration was associated with lower memory deficits than in untreated animals. Researchers discuss this in connection with neurodegeneration research; human data do not exist.

Neurodegeneration models. Fisetin has also been examined in animal models of Parkinson disease. In studies in which animals were given a chemical that induces Parkinson-like damage, fisetin-treated animals showed better motor function in the tests used. These results are the basis for further research; they say nothing about the progression of such conditions in humans.

Cardiovascular research. Because of its effects on inflammatory signalling in cells, fisetin is examined in cardiovascular research. Chronic inflammation is a risk factor for heart disease in the epidemiological literature. Animal studies have examined fisetin in relation to the function of blood vessels.

Skin research. Fisetin is also examined in dermatological research. In cell culture and animal models, fisetin was associated with lower skin damage after UV exposure, which researchers attribute to its antioxidant activity. Some studies also examined its effects on inflammatory markers in skin cells.

Doses used in studies and safety

The doses used in studies vary with the source and the research question. In many trials, doses between 100 mg and 1,000 mg per day were used; the ongoing senolytic trials in humans use 20 mg per kilogram of body weight on two consecutive days. It is important to note that higher doses are not necessarily better; any intake should be discussed with a physician. Fisetin is generally regarded as safe for consumption in the amounts found in food. No serious side effects have been reported, even at high doses in animal studies. Attention should nevertheless be paid to product quality.

Summary

Fisetin is a flavonoid with a broad research literature. Its antioxidant, inflammation-related and senolytic activities in cells and animals make it an interesting research topic in the field of ageing and age-related conditions. While further studies are required to understand the exact mechanisms and the long-term effects of fisetin in humans, it has produced results in animal models that researchers regard as a basis for the clinical trials now under way.

Fisetin as part of a balanced diet, for example through the consumption of strawberries, is the usual route of intake. Whether supplements have any relevance for ageing in humans is the subject of ongoing research. Overall, fisetin offers an interesting perspective for anyone following the science of ageing.